期刊文献+

厄贝沙坦对自发性高血压肾素—血管紧张素—醛固酮系统转化酶2mRNA表达的影响

The Effect of Irbesartan on Angiotensin Converting Enzyme2 mRNA of RAAS Expression in the Spontaneous Hypertensive Patients
下载PDF
导出
摘要 目的探讨厄贝沙坦对自发性高血压肾素—血管紧张素—醛固酮系统转换酶2mRNA表达的影响。方法 68例自发性高血压随机分为厄贝沙坦组和对照组,测定各组用药前后患者血压变化,外周血来源巨噬细胞ACE、ACE2 mRNA的含量变化。所获数据采用方差分析和t检验。结果各组治疗4周、8周后血压均降低,厄贝沙坦组降压效果优于对照组(P<0.05),治疗8周后厄贝沙坦组ACE2含量为(20.8±5.1)μl,对照组ACE2含量为(15.9±7.8)u/L,两组比较P<0.05,ACE2mRNA厄贝沙坦组为(0.71±0.07)μl,对照组(0.50±0.03)μl,两组比较P<0.01。结论厄贝沙坦降血压降压效果明显,其降压作用一方面通过与AngⅡAT1受体结合,另一方面通过增加ACE2活性及基因表达实现的。 Objective To observe the effect of irbesartan on the expression of angiotensin converting emzyme 2(ACE2)mRNA of renin-angiotensin-aldosterone system(RAAS) in the spontaneous hyperten-sive patients. Methods68 spontaneous hypertensive patients were randomly divided into two groups: irbesartan group and control group. Then the content of ACE and ACE2 in serum was detected by ELISA, and the expression of ACE mRNA and ACE2 mRNA in spontaneous hypertensive patients was detected by RT-PCR before and after having been treated. The data obtained using analysis of variance and t test. Results After having been treated for 4 weeks and 8 wddks,the blood pressure of patients in two groups were decreased sigifficantly,comparing with control group, irbesartan group seemed to have more obvious therapeutic effect(P〈0.05), in irbesartan group, the content of ACE2 in serum was increased after having been treated for 8 weeks than that in control group, [(20.8±5.1)u/l VS(15.9±7.8)u/l,P〈0.05 ]; and the expression of ACE2 mRNA in spontaneous hypertensive patients in irbesartan group was obviously increased after 8 weeks comparing with control treatment group [(0.71±0.07)VS(0.50±0.03), P〈0.01]. Conclusion Irbesartan can reduce blood-pressure by the up-regulation of ACE2 mRNA.
作者 张兆欐
出处 《菏泽医学专科学校学报》 2016年第1期18-20,74,共4页 Journal of Heze Medical College
关键词 肾素—血管紧张素—醛固酮系统 高血压/治疗 血管紧张素转化酶2 厄贝沙坦/治疗应用 Renin-angiotensin-aldosterone system(RAAS) Hypertension/therapy Rngiotensin converting enzyme 2(ACE2) Irbesartan/therapetuic use
  • 相关文献

参考文献9

  • 1I Perkovic V,Huxley R,Wu Y,et al,The burden of blood pressure related disease:a neglected priority for global health[J].Hypertension,2007,50:991-997.
  • 2Scott BB,Mc Geehan GM,Harrison RK.Development of inhibitors of the asperity protease rennin for the treatment of hypertension[J].Carr Protein Pelt Sci,2006,7(3):241-254.
  • 3符春晖,严华,陆永光,陈湘桂,黄军章.原发性高血压病患者肾素-血管紧张素-醛固酮系统活性的影响因素[J].中华实用诊断与治疗杂志,2011,25(7):633-635. 被引量:22
  • 4Santos RA,Ferreira AJ,Simoes E Simoms E Silva AC.Recent advances in the angiotensin-converting enzyme 2 angiotensin(1-7)-Mas axis[J].Exp Physiol,2008,93:510-526.
  • 5Mercer C,Yogi A,Caller G E,et al.Angiotensin(1-7)-blunts hypertensive cardiac remodeling by a direct effect on the heart Circ[J].Res,2008,103:1320-1326.
  • 6Zhong J,Bass R Guo D,et al.Angiotensin-converting enzyme2 suppresses Pathological hypertrophy,myocardial fibrosis,and cardiac dysfunction Circulation,2010,122:716-727.
  • 7Kadar S,Strizersky A,Raz A,et al.ACE2 activity is increased in monotype–drived macrophayes from prehyertensive subjects[J].Nephrol Dial Transplant,2007,22:597-601.
  • 8Keidar S,Camliel-Lazarovich A,Kaplan M,et al.Mineral corticoid receptor blocker increase angiotensin converting enzyme2 activity in congestive heart failure patients[J].Circ Res,2005,97:947-952.
  • 9Sukumaran V,Veeraveedu PT,Gurusamy N,et al.Cardioprotective effects of telmisartan against heart failure in rats induced by experimental.autoimmune myocarditis through the modulation of angiotensin converting enzyme 2/angiotensin1-7/mas receptor axis[J].Int[J].Biol Sci,2011,(7):1076-1090.

二级参考文献12

  • 1杨海芸,曹国良.不同剂量辛伐他汀对高血压病患者血管活性物质水平的影响[J].实用诊断与治疗杂志,2007,21(1):20-22. 被引量:18
  • 2中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防与控制指南[M].北京:人民卫生出版社,2006.
  • 3Grobe J l., Mecca A P, Lingis M, et al. Prevention of angiotensin Ⅱ induced cardiac remodeling by angiotensin (1 7) [J]. AmJ Physiol Heart CircPhysiol,2007,292(2):H736-742.
  • 4Jiang X, Sheng H, Li J, et al. Association between rennin angiotensin system gene polymorphism and essential hypertension: a community based study[J]. J Hum Hypertens, 2009,23(3) :176-181.
  • 5Jeunemaitre X. Genetics of the human renin angiotensin system [J]. J Mol Med,2008,86(6):637-641.
  • 6Hansen T W, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure[J]. Hypertension,2011,57(1) :3-10.
  • 7Hermida R C, Ayala D E, Fernandez J R, et al. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications [J]. AmJ Hypertens,2011,24(4):383-391.
  • 8Johansson J K, Niiranen T J, Puukka P J, et al. Factors affecting the variability of home-measured blood pressure and heart rate: the Finn home study[J]. J Hypertens,2010,28(9): 1836-1845.
  • 9Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter [J]. J BiolChem,2007,282(41):29821-29830.
  • 10林杰,田海宏,秦旭平.血管紧张素转换酶2与高血压[J].心血管病学进展,2009,30(1):69-71. 被引量:6

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部